Matthew Yglesias @mattyglesias
@ne0liberal @Noahpinion @jbarro Well one thing to note here is that the licensing trials are driven by the pharmaceutical companies not by the regulators. It’s not clear that getting a vaccine approved faster would’ve had upside for Moderna that would be worth the controversy. — PolitiTweet.org
